Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty

Recruiting Observational Study
Mitral Valve Prolapse Mitral Plasty
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mitral insufficiency (MI) accounts for 24% of adult valvulopathies and affects 7% of subjects older than 75 years. They are the second leading cause of valvulopathy in Europe. The most common etiology is the associated valvular prolapse. Mitral surgery remains the reference treatment for symptomatic MI. The success of this procedure depends on the mitral valve geometry and the location of the prol…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients operated between 1988 and 2011 * Presence of a valvular prolapse diagnosed by echocardiography * Possibility of a complete clinical evaluation at the time of the initial echocardiography Exclusion Criteria: * Ischemic MI (including papillary muscle rupture) * Presen…
Contacts

Catherine SZYMANSKI, Dr

+33322455885

szymanski.catherine@chu-amiens.fr

CONTACT